Three-year interim review of EIT Health and EIT Raw Materials.

The European Institute of Innovation and Technology plans to initiate a procurement for a three-year interim review of EIT Health and EIT Raw Materials. This planned procurement follows the expiration of an existing framework contract in August 2025. The procedure identifier for this opportunity is EIT/2025/MVP/0015-EXA. The lead authority for this contract is the EIT, focusing on business and management consultancy services categorized under the CPV code 79419000.

The contract will be a Direct Service Contract structured as a negotiated procedure, with no specific consortium requirements mentioned. Eligible applicants are expected to be consultancy firms, research institutes, and other organizations capable of delivering evaluation services. The project aims to assess the performance and impact of the two innovation communities, providing insights that will inform European innovation policy.

The maximum contract duration is set for 16 months, and the timeline includes a start date for submitting expressions of interest on August 6, 2025, with a deadline of August 20, 2025. The launch of the negotiated procedure is anticipated to happen on September 5, 2025. Although funding amounts are not specified, this is categorized as a low to middle-value contract.

Interested parties may express their interest electronically, and the procurement documentation will be made available through the specified channels. There is a section for questions and answers related to this procurement, enhancing clarity for potential bidders. In summary, this pre-announcement serves to inform stakeholders about the upcoming opportunity for evaluating these critical European innovation initiatives.

This is a publication announcing the European Institute of Innovation and Technology's (EIT) intention to publish a future negotiated low or middle value procedure. This is NOT a call for tenders. The procedure identifier is EIT/2025/MVP/0015-EXA.

The procurement is intended to conclude a Direct Service Contract for the provision of a 3-year interim review of EIT Raw Materials and EIT Health. This procedure is necessary because the initially planned interinstitutional FWC (FWC No.: EUROFOUND 21_3030_03) expires in August 2025.

The procedure type is a planned negotiated procedure for a middle/low value contract. The lead contracting authority is the European Institute of Innovation and Technology. The main classification (CPV) code is 79419000, which refers to evaluation consultancy services. The nature of the contract is for services. The maximum contract duration is 16 months. There is no framework agreement associated with this procurement.

The start date for expression of interest is 2025-08-06 Europe/Brussels. The deadline for expression of interest is 20/08/2025 05:59 Europe/Budapest. The indicative date of launch of the negotiated procedure is 2025-09-05 Europe/Budapest.

The method of expression of interest is electronic, and interested parties should express their interest electronically.

A question and answer section is available where users can log in to create questions, view public Q&As, access FAQs, and download Q&As in XLS format. One Q&A is already available: "Where can I find the procurement documents for calls for tenders with ‘ExA' in the reference?". The answer clarifies that references with 'ExA' are not calls for tenders but announcements of intent to launch a future negotiated procedure. This Q&A was published on 03/10/2024 at 17:32.

In summary, this is a pre-announcement for a future procurement by the EIT for a 3-year interim review of EIT Raw Materials and EIT Health. The actual call for tenders will be published later, and this announcement serves to inform potential bidders of the upcoming opportunity and allow them to express their interest. The procurement will be a negotiated procedure for a contract of middle or low value. The expression of interest phase is scheduled for August 2025, and the negotiated procedure is expected to launch in September 2025.

Eligible Applicant Types: The opportunity is a procurement for a service contract, so eligible applicants are likely to be organizations or companies that provide evaluation consultancy services. The specific types of organizations are not explicitly mentioned, but consultancy firms, research institutes with evaluation expertise, or similar entities would be suitable.

Funding Type: The funding type is a service contract, specifically a Direct Service Contract. This means the contracting authority will procure services from an external provider.

Consortium Requirement: The information does not explicitly state whether a consortium is required or if a single applicant is sufficient. However, given the nature of evaluation services, both single entities and consortia with relevant expertise could potentially apply.

Beneficiary Scope (Geographic Eligibility): The geographic eligibility is not explicitly stated. However, as the contracting authority is the European Institute of Innovation and Technology (EIT), it is highly likely that the opportunity is open to entities located in the EU and possibly EEA countries.

Target Sector: The target sector is evaluation consultancy services, specifically for the evaluation of EIT Health and EIT Raw Materials. This implies a focus on the health sector and the raw materials sector.

Mentioned Countries: No specific countries are mentioned, but the opportunity is managed by the European Institute of Innovation and Technology (EIT), suggesting a focus on EU member states. The start and deadline for expression of interest are given in Europe/Brussels and Europe/Budapest timezones.

Project Stage: The project stage is for the provision of evaluation services. This means the project involves assessing the performance and impact of existing initiatives (EIT Health and EIT Raw Materials) rather than developing new projects.

Funding Amount: The estimated total value is described as a middle/low value contract. While the exact amount is not specified, this suggests a funding range likely under €200k, possibly even under €50k, but this is speculative.

Application Type: The application type is a planned negotiated procedure. This means that after an expression of interest, the contracting authority will likely invite a select number of candidates to submit full proposals.

Nature of Support: The nature of support is non-monetary services. The selected applicant will receive a service contract to provide evaluation services, and in return, they will receive payment for their services.

Application Stages: The application process appears to involve at least two stages: an expression of interest and a subsequent invitation to submit a full proposal as part of the negotiated procedure.

Success Rates: The success rates are not mentioned. As a negotiated procedure typically involves a limited number of invited candidates, the success rate among those invited could be relatively higher than in open calls. However, the overall success rate from the initial expression of interest to contract award is unknown.

Co-funding Requirement: Co-funding is not mentioned, and it is unlikely to be required for a service contract of this nature.

Summary: This is a pre-announcement for a future negotiated procurement procedure by the European Institute of Innovation and Technology (EIT). The EIT intends to contract an organization or company to conduct a three-year interim review of EIT Health and EIT Raw Materials. This is not a call for tenders yet, but rather a notification that a negotiated procedure for a low or middle value contract will be launched in the future. Interested parties are invited to express their interest electronically. The procedure identifier is EIT/2025/MVP/0015-EXA. The start date for expression of interest is planned for August 6, 2025, with a deadline of August 20, 2025. The indicative date for the launch of the negotiated procedure is September 5, 2025. The maximum contract duration is 16 months. The selected contractor will provide evaluation consultancy services. The opportunity is relevant for organizations with expertise in evaluating programs in the health and raw materials sectors.